In this study we assessed whether nonpromoter CDKN2A methylation in laryngeal squamous cell carcinomas (LXSCC) conferred a similar association with transcription that predicted patient outcome. This evidence concerns the gene CDKN2A and laryngeal squamous cell carcinoma.